These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 12678804

  • 1. QSAR-derived choline kinase inhibitors: how rational can antiproliferative drug design be?
    Campos J, Núñez MC, Conejo-García A, Sánchez-Martín RM, Hernández-Alcoceba R, Rodríguez-González A, Lacal JC, Gallo MA, Espinosa A.
    Curr Med Chem; 2003 Jul; 10(13):1095-112. PubMed ID: 12678804
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. (Q)SAR studies to design new human choline kinase inhibitors as antiproliferative drugs.
    Campos JM, Sánchez-Martín RM, Conejo-García A, Entrena A, Gallo MA, Espinosa A.
    Curr Med Chem; 2006 Jul; 13(11):1231-48. PubMed ID: 16712467
    [Abstract] [Full Text] [Related]

  • 5. Choline kinase inhibitory effect and antiproliferative activity of new 1,1',1"-(benzene-1,3,5-triylmethylene)tris[4-[(disubstituted)amino]pyridinium] tribromides.
    Conejo-García A, Campos J, Sánchez RM, Rodríguez-González A, Lacal JC, Gallo MA, Espinosa A.
    Eur J Med Chem; 2003 Jan; 38(1):109-16. PubMed ID: 12593921
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivity.
    Hong BS, Allali-Hassani A, Tempel W, Finerty PJ, Mackenzie F, Dimov S, Vedadi M, Park HW.
    J Biol Chem; 2010 May 21; 285(21):16330-40. PubMed ID: 20299452
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery.
    Hernández-Alcoceba R, Fernández F, Lacal JC.
    Cancer Res; 1999 Jul 01; 59(13):3112-8. PubMed ID: 10397253
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases.
    Lacal JC, Zimmerman T, Campos JM.
    Pharmaceutics; 2021 May 25; 13(6):. PubMed ID: 34070409
    [Abstract] [Full Text] [Related]

  • 20. A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products.
    Estévez-Braun A, Ravelo AG, Pérez-Sacau E, Lacal JC.
    Clin Transl Oncol; 2015 Jan 25; 17(1):74-84. PubMed ID: 25472447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.